Study title:
Oberlin-O, Leverger-G, Pacquement-H, Raquin-M-A, Chompret-A, Habrand- J-L, Terrier-Lacombe-M-J, Bey-P, Bertrand-Y, Rubie-H, et al.
Pediatrics Department, Institut Gustave Roussy, Villejuif, France.
Low-dose radiation therapy and reduced chemotherapy in childhood
Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Journal of clinical oncology : official journal of the American
Society of Clinical Oncology, {J-Clin-Oncol}, Oct 1992, vol. 10, no. 10, p. 1602-8, ISSN: 0732-183X.Oberlin-O, Leverger-G, Pacquement-H, Raquin-M-A, Chompret-A, Habrand- J-L, Terrier-Lacombe-M-J, Bey-P, Bertrand-Y, Rubie-H, et al.
Pediatrics Department, Institut Gustave Roussy, Villejuif, France.
Low-dose radiation therapy and reduced chemotherapy in childhood
Hodgkin's...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|